Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 623

1.

Recent advances in modulating the microbiome.

Quigley EMM, Gajula P.

F1000Res. 2020 Jan 27;9. pii: F1000 Faculty Rev-46. doi: 10.12688/f1000research.20204.1. eCollection 2020. Review.

2.

Polyethylene glycol-based laxatives for chronic constipation - Authors' reply.

Luthra P, Camilleri M, Burr NE, Quigley EMM, Black CJ, Ford AC.

Lancet Gastroenterol Hepatol. 2020 Feb;5(2):110-111. doi: 10.1016/S2468-1253(19)30381-4. Epub 2020 Jan 8. No abstract available.

PMID:
31928990
3.

The microbiome and inflammatory bowel disease.

Glassner KL, Abraham BP, Quigley EMM.

J Allergy Clin Immunol. 2020 Jan;145(1):16-27. doi: 10.1016/j.jaci.2019.11.003.

PMID:
31910984
4.

Cancer cachexia: a multifactoral disease that needs a multimodal approach.

Stubbins R, Bernicker EH, Quigley EMM.

Curr Opin Gastroenterol. 2020 Mar;36(2):141-146. doi: 10.1097/MOG.0000000000000603.

PMID:
31895232
5.

Antibiotics and probiotics in inflammatory bowel disease: when to use them?

Abraham B, Quigley EMM.

Frontline Gastroenterol. 2020 Jan;11(1):62-69. doi: 10.1136/flgastro-2018-101057. Epub 2019 Mar 22. Review.

PMID:
31885842
6.

Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.

Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC.

Lancet Gastroenterol Hepatol. 2020 Feb;5(2):117-131. doi: 10.1016/S2468-1253(19)30324-3. Epub 2019 Dec 16.

PMID:
31859183
7.

Commentary: faecal microbiota transplantation-from home brew to holy grail.

Quigley EMM.

Aliment Pharmacol Ther. 2020 Jan;51(1):208-209. doi: 10.1111/apt.15553. No abstract available.

PMID:
31850583
8.

Editorial: Nutrition in gastroenterology: more relevant than ever yet largely ignored in our education and training.

Quigley EMM.

Curr Opin Gastroenterol. 2020 Mar;36(2):99-100. doi: 10.1097/MOG.0000000000000602. No abstract available.

PMID:
31833967
9.

Choosing a Prokinetic for Your Patient Beyond Metoclopramide.

Gudsoorkar V, Quigley EMM.

Am J Gastroenterol. 2020 Jan;115(1):5-8. doi: 10.14309/ajg.0000000000000463. No abstract available.

PMID:
31714358
10.

Microbiome Modulation in Liver Disease.

Quigley EMM.

Clin Liver Dis (Hoboken). 2019 Nov 6;14(4):149-151. doi: 10.1002/cld.862. eCollection 2019 Oct. Review. No abstract available.

11.

Nutraceuticals as modulators of gut microbiota: Role in therapy.

Quigley EMM.

Br J Pharmacol. 2019 Oct 29. doi: 10.1111/bph.14902. [Epub ahead of print] Review.

PMID:
31659751
12.

Gastrointestinal lymphoma: the new mimic.

Shirwaikar Thomas A, Schwartz M, Quigley E.

BMJ Open Gastroenterol. 2019 Sep 13;6(1):e000320. doi: 10.1136/bmjgast-2019-000320. eCollection 2019. Review.

13.

Editorial: Colon updates 2020 - some old, some new but novel insights throughout.

Quigley EMM.

Curr Opin Gastroenterol. 2020 Jan;36(1):17-18. doi: 10.1097/MOG.0000000000000595. No abstract available.

PMID:
31633564
14.

To help or punish in the face of unfairness: men and women prefer mutually-beneficial strategies over punishment in a sexual selection context.

Ferguson E, Quigley E, Powell G, Stewart L, Harrison F, Tallentire H.

R Soc Open Sci. 2019 Sep 4;6(9):181441. doi: 10.1098/rsos.181441. eCollection 2019 Sep.

15.

Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.

Avelar Rodriguez D, Ryan PM, Toro Monjaraz EM, Ramirez Mayans JA, Quigley EM.

Front Pediatr. 2019 Sep 4;7:363. doi: 10.3389/fped.2019.00363. eCollection 2019. Review.

16.

The challenges of primary biliary cholangitis: What is new and what needs to be done.

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME.

J Autoimmun. 2019 Dec;105:102328. doi: 10.1016/j.jaut.2019.102328. Epub 2019 Sep 20. Review.

PMID:
31548157
17.

Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.

Luthra P, Camilleri M, Burr NE, Quigley EMM, Black CJ, Ford AC.

Lancet Gastroenterol Hepatol. 2019 Nov;4(11):831-844. doi: 10.1016/S2468-1253(19)30246-8. Epub 2019 Aug 29.

PMID:
31474542
18.

The Gut Microbiome Influences Responses to Programmed Death 1 Therapy in Chinese Lung Cancer Patients - the Benefits of Diversity.

Bernicker EH, Quigley EMM.

J Thorac Oncol. 2019 Aug;14(8):1319-1322. doi: 10.1016/j.jtho.2019.05.016. No abstract available.

PMID:
31345329
19.

Symptoms and the small intestinal microbiome - the unknown explored.

Quigley EMM.

Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):457-458. doi: 10.1038/s41575-019-0171-5. No abstract available.

PMID:
31213706
20.

Editorial: Lactobacillus GG for diarrhoea in children-reports of its demise have been premature!

Quigley EMM.

Aliment Pharmacol Ther. 2019 Jun;49(12):1533-1534. doi: 10.1111/apt.15288. No abstract available.

PMID:
31134655
21.

Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.

Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, Houghton LA, Ford AC.

Gut. 2020 Jan;69(1):74-82. doi: 10.1136/gutjnl-2018-318160. Epub 2019 Apr 17.

PMID:
30996042
22.

Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.

Aliment Pharmacol Ther. 2019 May;49(9):1254-1255. doi: 10.1111/apt.15234. No abstract available.

PMID:
30977174
23.

Overlapping irritable bowel syndrome and inflammatory bowel disease.

Gajula P, Quigley EM.

Minerva Gastroenterol Dietol. 2019 Jun;65(2):107-115. doi: 10.23736/S1121-421X.19.02559-5. Epub 2019 Feb 11. Review.

PMID:
30746927
24.

Bifidobacterium animalis subspecies lactis engineered to produce mycosporin-like amino acids in colorectal cancer prevention.

Bozkurt HS, Quigley EM, Kara B.

SAGE Open Med. 2019 Jan 22;7:2050312119825784. doi: 10.1177/2050312119825784. eCollection 2019. Review.

25.

Systematic review with meta-analysis: cholecystectomy for biliary dyskinesia-what can the gallbladder ejection fraction tell us?

Gudsoorkar VS, Oglat A, Jain A, Raza A, Quigley EMM.

Aliment Pharmacol Ther. 2019 Mar;49(6):654-663. doi: 10.1111/apt.15128. Epub 2019 Jan 31. Review.

PMID:
30706496
26.

The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO).

Quigley EMM.

Curr Gastroenterol Rep. 2019 Jan 15;21(1):3. doi: 10.1007/s11894-019-0671-z. Review.

PMID:
30645678
27.

Editorial: Thought for food: diet and gut health.

Quigley EMM.

Curr Opin Gastroenterol. 2019 Mar;35(2):99-100. doi: 10.1097/MOG.0000000000000505. No abstract available.

PMID:
30585792
28.

Highlights of the Updated Evidence-Based IBS Treatment Monograph.

Quigley EMM.

Gastroenterol Hepatol (N Y). 2018 Nov;14(11):665-667. No abstract available.

29.

Editorial: From eosinophils to serrated adenomas and beyond: late breaking news from the dark continent.

Quigley EMM.

Curr Opin Gastroenterol. 2019 Jan;35(1):25-26. doi: 10.1097/MOG.0000000000000496. No abstract available.

PMID:
30489413
30.

Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches.

Alamo RZ, Quigley EMM.

Curr Opin Gastroenterol. 2019 Jan;35(1):27-33. doi: 10.1097/MOG.0000000000000499. Review.

PMID:
30407258
31.

Magnetic Resonance Imaging and Clinical Factors Associated With Ischemic Stroke in Patients Suspected of Cervical Artery Dissection.

McNally JS, Hinckley PJ, Sakata A, Eisenmenger LB, Kim SE, De Havenon AH, Quigley EP, Iacob E, Treiman GS, Parker DL.

Stroke. 2018 Oct;49(10):2337-2344. doi: 10.1161/STROKEAHA.118.021868.

32.

The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards?

Di Stefano M, Quigley EMM.

Neurogastroenterol Motil. 2018 Nov;30(11):e13494. doi: 10.1111/nmo.13494. Review.

PMID:
30328232
33.

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.

Aliment Pharmacol Ther. 2018 Nov;48(10):1044-1060. doi: 10.1111/apt.15001. Epub 2018 Oct 8.

PMID:
30294792
34.

Prebiotics and Probiotics in Digestive Health.

Quigley EMM.

Clin Gastroenterol Hepatol. 2019 Jan;17(2):333-344. doi: 10.1016/j.cgh.2018.09.028. Epub 2018 Sep 26. Review.

PMID:
30267869
35.

'Brain Fogginess' and D-Lactic Acidosis: Probiotics Are Not the Cause.

Quigley EMM, Pot B, Sanders ME.

Clin Transl Gastroenterol. 2018 Sep 24;9(9):187. doi: 10.1038/s41424-018-0057-9. No abstract available.

36.

Reply.

Quigley EMM, Koduru P, Irani M.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1679. doi: 10.1016/j.cgh.2018.05.053. No abstract available.

PMID:
30243352
37.

Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P.

Am J Gastroenterol. 2019 Jan;114(1):21-39. doi: 10.1038/s41395-018-0222-5.

38.

Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.

Black CJ, Burr NE, Quigley EMM, Moayyedi P, Houghton LA, Ford AC.

Gastroenterology. 2018 Dec;155(6):1753-1763. doi: 10.1053/j.gastro.2018.08.021. Epub 2018 Aug 23.

39.

Tunable Interfacial Properties in Silk Ionomer Microcapsules with Tailored Multilayer Interactions.

Geryak R, Quigley E, Kim S, Korolovych VF, Calabrese R, Kaplan DL, Tsukruk VV.

Macromol Biosci. 2019 Mar;19(3):e1800176. doi: 10.1002/mabi.201800176. Epub 2018 Aug 13.

PMID:
30102459
40.

A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.

Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, Quigley EMM, Moayyedi P.

Am J Gastroenterol. 2018 Sep;113(9):1290-1300. doi: 10.1038/s41395-018-0195-4. Epub 2018 Jul 26.

41.

American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome.

Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE, Saito YA, Quigley EMM; ACG Task Force on Management of Irritable Bowel Syndrome.

Am J Gastroenterol. 2018 Jun;113(Suppl 2):1-18. doi: 10.1038/s41395-018-0084-x. No abstract available.

42.

Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire.

Quigley EMM, Horn J, Kissous-Hunt M, Crozier RA, Harris LA.

Adv Ther. 2018 Jul;35(7):967-980. doi: 10.1007/s12325-018-0733-x. Epub 2018 Jun 26.

PMID:
29946799
43.

C1 Posterior Arch Flare Point: A Useful Landmark for Fluoroscopically Guided C1-2 Puncture.

Peckham ME, Shah LM, Tsai AC, Quigley EP 3rd, Cramer J, Hutchins TA.

AJNR Am J Neuroradiol. 2018 Aug;39(8):1562-1567. doi: 10.3174/ajnr.A5706. Epub 2018 Jun 21.

44.

A Critical Review of the Current Clinical Landscape of Gastroparesis.

Fosso CL, Quigley EMM.

Gastroenterol Hepatol (N Y). 2018 Mar;14(3):140-145.

45.

A Probiotic for Ulcerative Colitis: The Culture Wars Continue.

Abraham BP, Quigley EMM.

Dig Dis Sci. 2018 Jul;63(7):1678-1680. doi: 10.1007/s10620-018-5097-1. No abstract available.

PMID:
29785650
46.

Autoimmune liver disease and the enteric microbiome.

Glassner K, Quigley EM, Franco L, Victor DW 3rd.

AIMS Microbiol. 2018 May 14;4(2):334-346. doi: 10.3934/microbiol.2018.2.334. eCollection 2018. Review.

47.

Dual-Excitation Nanocellulose Plasmonic Membranes for Molecular and Cellular SERS Detection.

Zhang S, Xiong R, Mahmoud MA, Quigley EN, Chang H, El-Sayed M, Tsukruk VV.

ACS Appl Mater Interfaces. 2018 May 30;10(21):18380-18389. doi: 10.1021/acsami.8b04817. Epub 2018 May 18.

PMID:
29737825
48.

Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective.

Giron F, Quigley EMM.

J Neurogastroenterol Motil. 2018 Jul 30;24(3):355-366. doi: 10.5056/jnm18004. Review.

49.

Therapeutic implications of the gastrointestinal microbiome.

Kashyap PC, Quigley EM.

Curr Opin Pharmacol. 2018 Feb;38:90-96. doi: 10.1016/j.coph.2018.01.004. Epub 2018 Feb 6. Review.

PMID:
29426776
50.

Carbohydrate Maldigestion and Malabsorption.

Omer A, Quigley EMM.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1197-1199. doi: 10.1016/j.cgh.2018.01.048. Epub 2018 Feb 6. Review. No abstract available.

PMID:
29425782

Supplemental Content

Loading ...
Support Center